| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.8 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |